A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
Clinical trial NCT03576417 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03576417
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2027-08-01
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.